Life ScienceCompany
Xellia Pharmaceuticals Ownership
Who owns Xellia Pharmaceuticals?
Xellia Pharmaceuticals is owned by Novo Holdings A/S. It was acquired on May 21, 2013.
Is Xellia Pharmaceuticals PE-backed?
Yes. Xellia Pharmaceuticals is owned by private equity investor Novo Holdings A/S.
Was Xellia Pharmaceuticals formerly PE-backed?
Yes. Xellia Pharmaceuticals was formerly owned by 1 private investor.
Xellia Pharmaceuticals Business Overview
Where is Xellia Pharmaceuticals headquartered?
Xellia Pharmaceuticals is headquartered in Copenhagen, Denmark.
What sector is Xellia Pharmaceuticals in?
Xellia Pharmaceuticals is a life science company.
When was Xellia Pharmaceuticals founded?
Xellia Pharmaceuticals was founded in 1994.
Life Science M&A Summary in 2013
Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2013. The largest life science acquisition in 2013 was Onyx Pharmaceuticals - which was acquired by Amgen for $10.4B.
Join Mergr to view all 192 acquisitions of life science companies in 2013, including 26 acquisitions by private equity firms, and 166 by strategics.